MHRA Issues Guidance On Recognizing And Reporting Medtech Software Adverse Events
When it comes to medtech adverse events incidents may not always be obvious. This is especially the case with medical device software where indirect harm is the most likely outcome of an incident, the UK’s MHRA explains in new guidance.
You may also be interested in...
UK MHRA Gives CE-Marked Devices More Breathing Space In GB
The long-awaited extension of the UK MHRA’s standstill period for CE-marked devices circulating on the Great Britain market was announced in late April, offering new transition deadlines that go beyond the one extra year promised by the agency in fall 2022. Industry is studying the implications.
UK Updates Guidance To Reflect EU Medtech Extensions - Pledges Focus On Agility, Innovation
The EU’s decision to extend the Medical Device Regulation transition periods for legacy medical device directives products will be mirrored in the UK, which also continues to evolve its post-Brexit medtech regulatory system.
MedTech Forum 2023: Why The Commission Must Not ‘Shoot For The Moon’ With EHDS Plans
EU policymakers have ambitious goals to enable greater sharing of electronic health data through the creation of a European Health Data Space, but experts at the MedTech Forum conference urged the commission to ensure its regulation is implementable.